⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 27, 2024CureusOpen Access

A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System Events for Trametinib

Xinyue Zhang Rongrong Li Yanrong Li Lu He Encun Hou

View Full Paper

Ask AI

Bookmark

Share

Abstract

This research investigates adverse drug events (ADEs) linked to trametinib, utilizing data from the FDA Adverse Event Reporting System (FAERS) database, covering the period from Q2 2013 to Q4 2023.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e5ab93b6db6435875458e5 https://doi.org/10.7759/cureus.67925

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A real-world pharmacovigilance analysis for transthyretin inhibitors: findings from the FDA adverse event reporting database2024 · 7 citations
2Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the <scp>FDA</scp> Adverse Event Reporting System (<scp>FAERS</scp>) Database2025 · 2 citations
3Adverse events with pemigatinib in the real world: a pharmacovigilance study based on the FDA adverse event reporting system2024 · 3 citations
4Neratinib safety evaluation: real-world adverse event analysis from the FAERS database2024 · 17 citations
5Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study2024 · 3 citations

More related papers

Pharmacovigilance analysis of the FGFR inhibitor futibatinib using the FDA adverse event reporting system (FAERS) database2026
Treatment-Related Adverse Events in Individuals with BRAF-Mutant Cutaneous Melanoma Treated with BRAF and MEK Inhibitors: A Systematic Review and Meta-Analysis2025
Post-marketing safety surveillance of fostamatinib: an observational, pharmacovigilance study leveraging FAERS database2024

More from Cureus

Late-Presenting Myocardial Infarction With Separate Anomalous Right-Sided Origins of the Left Anterior Descending and Circumflex Arteries: A Case ReportFri,
The Copper-Zinc Balance in Hypertension: A Cross-Sectional Study From BangladeshFri,